Unique Ingredient Identifier A2I8C7HI9T is listed as a ingredient substance
| RN | 99-76-3 |
| EC | 202-785-7 |
| NCIT | C76720 |
| RXCUI | 29903 |
| PUBCHEM | 7456 |
| MF | C8H8O3 |
| INCHI KEY | LXCFILQKKLGQFO-UHFFFAOYSA-N |
| SMILES | COC(=O)C1=CC=C(O)C=C1 |
UNII A2I8C7HI9T METHYLPARABEN is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | 0.1 % |
| AURICULAR (OTIC) | SUSPENSION | 0.001 % |
| BUCCAL | FILM | 1 MG |
| BUCCAL | FILM, SOLUBLE | 0.71 MG |
| CAUDAL BLOCK | INJECTION | 0.1 % |
| EPIDURAL | INJECTION | 0.1 % |
| EPIDURAL | LIQUID, WATER, STERILE, FOR INJECTION | 5 % |
| IM - IV | INJECTABLE | 0.12 % |
| IM - IV | INJECTION | 0.75 % |
| IM - IV | POWDER, FOR INJECTION SOLUTION | 0.36 % |
| IM - IV | SOLUTION | 0.13 % |
| IM - IV - SC | INJECTION | 0.44 % |
| IM - SC | INJECTION | 0.18 % |
| INFILTRATION | INJECTION | 1 MG/1ML |
| INFILTRATION | INJECTION | 0.1 % |
| INHALATION | SOLUTION | 2750 MG/INH |
| INTRA-ARTERIAL | INJECTION | NA |
| INTRA-ARTICULAR | INJECTION | 0.24 % |
| INTRABURSAL | INJECTION | 0.18 % |
| INTRADERMAL | INJECTION | 0.1 % |
| INTRALESIONAL | INJECTION | 0.15 % |
| INTRAMUSCULAR | INJECTABLE | 0.18 %W/V |
| INTRAMUSCULAR | INJECTION | 1 MG/1ML |
| INTRAMUSCULAR | INJECTION | 0.38 %W/V |
| INTRAMUSCULAR | INJECTION, SOLUTION | 1.8 MG/1ML |
| INTRAMUSCULAR | INJECTION, SUSPENSION | 0.14 % |
| INTRAMUSCULAR | SOLUTION, INJECTION | NA |
| INTRAMUSCULAR | SUSPENSION | 0.18 % |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 1.37 MG/1ML |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 0.14 %W/V |
| INTRASYNOVIAL | INJECTION | NA |
| INTRATUMOR | INJECTION | 0.08 % |
| INTRAVASCULAR | INJECTION | 0.1 % |
| INTRAVENOUS | INJECTABLE | 0.72 % |
| INTRAVENOUS | INJECTION | 1 MG/1ML |
| INTRAVENOUS | INJECTION | 0.75 % |
| INTRAVENOUS | INJECTION, SOLUTION | 1.8 MG/1ML |
| INTRAVENOUS | LIQUID, WATER, STERILE, FOR INJECTION | 0.18 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 1.5 % |
| INTRAVENOUS | SOLUTION, INJECTION | 0.18 % |
| INTRAVENOUS INFUSION | INJECTION | 1.8 MG/1ML |
| IONTOPHORESIS | SOLUTION | 0.1 % |
| IRRIGATION | SOLUTION | 2 % |
| IV - SC | INJECTION | 1.5 MG/1ML |
| IV - SC | INJECTION | 0.18 % |
| IV(INFUSION) | INJECTION | 0.44 % |
| IV(INFUSION) | LIQUID, WATER, STERILE, FOR INJECTION | 5 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 0.36 % |
| NASAL | SOLUTION | 0.033 % |
| NASAL | SPRAY, METERED | 0.7 % |
| NERVE BLOCK | INJECTION | 1 MG/1ML |
| NERVE BLOCK | INJECTION | 0.1 % |
| OPHTHALMIC | OINTMENT | 0.05 % |
| OPHTHALMIC | SOLUTION | 0.05 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.053 % |
| OPHTHALMIC | SUSPENSION | 0.05 % |
| OPHTHALMIC | SUSPENSION, DROPS | 0.05 % |
| ORAL | CAPSULE | 1 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL | 0.32 MG |
| ORAL | CAPSULE, COATED, SOFT GELATIN | 0.21 MG |
| ORAL | CAPSULE, HARD GELATIN | NA |
| ORAL | CAPSULE, SOFT GELATIN | 0.68 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 0.86 MG |
| ORAL | CONCENTRATE | 2 MG/1ML |
| ORAL | DROPS | NA |
| ORAL | EMULSION | NA |
| ORAL | GRANULE | 50 MG |
| ORAL | LIQUID | 10.13 mg/10mL |
| ORAL | LIQUID | 2 MG |
| ORAL | POWDER | 0.16 % |
| ORAL | POWDER, FOR ORAL SOLUTION | 1.51 MG |
| ORAL | POWDER, FOR ORAL SUSPENSION | 0.38 %W/W |
| ORAL | POWDER, FOR SOLUTION | 1.58 MG/1ML |
| ORAL | POWDER, FOR SUSPENSION | 5 MG/5ML |
| ORAL | SOLUTION | 15 MG |
| ORAL | SOLUTION | 12 mg/15 mL |
| ORAL | SOLUTION | 2 MG/ML |
| ORAL | SOLUTION, CONCENTRATE | 1 MG/1ML |
| ORAL | SOLUTION, ELIXIR | 9 MG/5ML |
| ORAL | SOLUTION, LIQUID | 2 MG/1ML |
| ORAL | SOLUTION, SYRUP | 9 MG/5ML |
| ORAL | SUSPENSION | 1000 MG/5ML |
| ORAL | SUSPENSION | 6.6 MG/15ML |
| ORAL | SUSPENSION | 2.12 mg/1mL |
| ORAL | SUSPENSION, EXTENDED RELEASE | 10 MG/5ML |
| ORAL | SUSPENSION, EXTENDED RELEASE | 1.8 MG/1ML |
| ORAL | SUSPENSION, LIQUID | 10 MG/5ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 7.5 MG/5ML |
| ORAL | TABLET | 1.8 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 1.27 MG |
| ORAL | TABLET, COATED | 0.016 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 0.081 MG |
| ORAL | TABLET, FILM COATED | 0.23 MG |
| ORAL | TABLET, SUSTAINED ACTION | 0.17 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | NA |
| PARENTERAL | INJECTION | 0.18 % |
| PARENTERAL | LIQUID, WATER, STERILE, FOR INJECTION | 5 % |
| PERIDURAL | INJECTION | 0.1 % |
| RECTAL | AEROSOL, METERED | 0.09 % |
| RECTAL | ENEMA | 0.18 % |
| RECTAL | LIQUID | 0.13 % |
| RECTAL | SOLUTION | 0.13 % |
| RECTAL | SUSPENSION | 0.23 % |
| SOFT TISSUE | INJECTION | 0.15 % |
| SUBCUTANEOUS | INJECTION | 0.3 % |
| SUBCUTANEOUS | SUSPENSION, INJECTION | 0.25 % |
| TOPICAL | CREAM | 0.2 %W/W |
| TOPICAL | CREAM, AUGMENTED | 0.2 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.2 %W/W |
| TOPICAL | EMULSION | 0.2 %W/W |
| TOPICAL | EMULSION, AEROSOL FOAM | 0.11 %W/W |
| TOPICAL | EMULSION, CREAM | 0.5 %W/W |
| TOPICAL | EMULSION, LOTION | 0.17 %W/W |
| TOPICAL | FILM, CONTROLLED RELEASE | 14 MG |
| TOPICAL | GEL | 0.3 %W/W |
| TOPICAL | JELLY | 0.07 %W/V |
| TOPICAL | LOTION | 0.3 %W/W |
| TOPICAL | OINTMENT | 0.2 %W/W |
| TOPICAL | PATCH | NA |
| TOPICAL | PATCH, CONTROLLED RELEASE | NA |
| TOPICAL | SHAMPOO | 0.15 %W/W |
| TOPICAL | SHAMPOO, SUSPENSION | 0.15 %W/W |
| TOPICAL | SOLUTION | 0.1 %W/W |
| TOPICAL | SPRAY | 0.2 %W/W |
| TOPICAL | SUSPENSION | 0.3 %W/W |
| URETERAL | SOLUTION | NA |
| URETHRAL | INJECTION | 0.18 % |
| URETHRAL | JELLY | 0.07 % |
| VAGINAL | CREAM | 0.2 %W/W |
| VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.18 % |
| VAGINAL | EMULSION, AEROSOL FOAM | 0.1 % |
| VAGINAL | EMULSION, CREAM | 0.2 % |
| VAGINAL | GEL | 0.08 % |
| VAGINAL | SUPPOSITORY | NA |